• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Rydex Biotechnology Inv (RYOIX)

    85.57 Up 0.74(0.87%) Dec 19
    Prev Close:84.83
    YTD Return*:33.50%
    Net Assets*:539.54M
    Yield*:N/A

    * As of 30-Nov-14

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Top Holdings

    Symbol% AssetsYTD Return %
    GILD6.5636.07
    AMGN6.5250.53
    CELG5.7236.36
    BIIB4.4517.42
    REGN3.7253.04

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:539.54M
    Category:Health
    Annual Report Expense Ratio (net):1.36%

    Performance & Risk

    YTD Return:33.50%
    5y Avg Return:29.22%
    Rank in Category (ytd):1
    % Rank in Category (ytd):0.79%
    Beta (3y):0.82
    Morningstar Risk Rating:5

    Fund Summary

    The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It will invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback